
Oxford Nanopore Technologies
Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
Latest Content

Webinar
Introducing Cancer Genomics With Long Reads
On-Demand
The last twenty years have experienced extensive growth in the sequencing of cancer genomes, leading to a dramatically increased understanding of the role of genetic and epigenetic mutations in cancer.

Video
Adaptive Sampling: Target Regions of DNA in Real Time
It’s possible to target regions of DNA in real time using adaptive sampling on nanopore devices. The nanopore has the ability to read the strand sequence in real time, if it is not the strand of interest, the strand is ejected, but if it is, the nanopore recognises this and continues to read the strand. Researchers then get more of the sequence they are interested in within a shorter period of time, allowing faster and easier analysis.

News
How the Placement of a Gene Affects Its Expression
Genomes are made up of thousands of individual pieces – genes – which are expressed at different levels. Researchers at EMBL have shed light on how the placement of a gene affects its expression, as well as that of its neighbours.

Video
ORG.one: Supporting Sequencing of Critically Endangered Species
Oxford Nanopore launched ORG.one to support faster, more localised sequencing of critically endangered species.

Webinar
Unlocking Plant 3D Genome Architecture With Pore-C Sequencing
On-Demand
In this webinar, New York University’s Dr. Jae Young Choi will discuss how to perform Pore-C sequencing in plant species to generate chromosome-level genome assemblies and map chromatin interactions to identify candidate enhancer‒gene interactions.

News
Rare Genetic Diseases Rapidly Diagnosed by Mega-Sequencing Approach
A new ultra-rapid genome sequencing approach developed by scientists has been used to diagnose rare genetic diseases in an average of eight hours.
Advertisement